期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Hyperlactatemia in patients with non-acetaminophen-related acute liver failure 被引量:2
1
作者 Pilar Taurá Graciela Martinez-Palli +6 位作者 Julia Martinez-Ocon Joan Beltran Gerard Sanchez-Etayo Jaume Balust teresa anglada Antoni Mas Juan-Carlos Garcia-Valdecasas 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第12期1949-1953,共5页
AIM: To characterize hyperlactatemia in patients with non-acetaminophen acute liver failure (ALF) in an attempt to clarify the mechanisms implicated and the role as a prognosis factor. METHODS: In the setting of l... AIM: To characterize hyperlactatemia in patients with non-acetaminophen acute liver failure (ALF) in an attempt to clarify the mechanisms implicated and the role as a prognosis factor. METHODS: In the setting of liver transplantation, 63 consecutive patients with non-acetaminophen acute liver failure were studied in relation to tissue oxygenation, hemodynamic and metabolic parameters. Before and after transplantation, the number of infected patients and outcome were registered. RESULTS: Acute ALF showed higher levels of lactate than subacute ALF (5.4 ± 1 mmol/L versus 2.2 ± 0.6 mmol/L, P= 0.01). Oxygenation parameters were within the normal range. Lactate levels showed good correlation with respiratory quotient (r=0.759, P〈 0.005), mean glucose administration (r= 0.664, P= 0.01) and encephalopathy (r= 0.698, P= 0.02), but not with splanchnic arteriovenous difference in PCO2, pH and the presence of infection (P=0.1). Portal vein lactate was higher (P〈0.05) than arterial and mixed venous lactate, suggesting its production of hyperlactatemia in the intestine and spleen. The presence of infection was an independent predictor of survival. CONCLUSION: Hyperlactatemia is not a prognosis factor due to byproduct of the overall acceleration in glycolysis. 展开更多
关键词 Hyperlactatemia Non-acetaminophen acuteliver failure Splanchnic hypoperfusion Acute liverfailure
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部